OptimizeRx (OPRX) Shares Outstanding (2016 - 2024)
Historic Shares Outstanding for OptimizeRx (OPRX) over the last 16 years, with Q4 2024 value amounting to $20.2 million.
- OptimizeRx's Shares Outstanding rose 148.25% to $20.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $20.2 million, marking a year-over-year increase of 148.25%. This contributed to the annual value of $20.2 million for FY2024, which is 148.25% up from last year.
- As of Q4 2024, OptimizeRx's Shares Outstanding stood at $20.2 million, which was up 148.25% from $20.1 million recorded in Q3 2024.
- OptimizeRx's 5-year Shares Outstanding high stood at $20.2 million for Q4 2024, and its period low was $2695.0 during Q1 2021.
- Its 5-year average for Shares Outstanding is $17.0 million, with a median of $18.2 million in 2022.
- In the last 5 years, OptimizeRx's Shares Outstanding tumbled by 9998.62% in 2021 and then soared by 89361253.07% in 2022.
- Over the past 5 years, OptimizeRx's Shares Outstanding (Quarter) stood at $15.2 million in 2020, then rose by 17.33% to $17.9 million in 2021, then increased by 2.39% to $18.3 million in 2022, then grew by 8.81% to $19.9 million in 2023, then rose by 1.48% to $20.2 million in 2024.
- Its Shares Outstanding stands at $20.2 million for Q4 2024, versus $20.1 million for Q3 2024 and $20.1 million for Q2 2024.